Skip to content
★ Sign in to follow
KE

Kathryn E. Stein

Executive
Total declarations
17
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (6 ops.)
€1.5M

Latest filing published 11 Jan 2016 for Macrogenics INC.

Insider track record

Disclosed buys
0
Disclosed sells
6
Signal history

No signal scores available.

Kathryn E. Stein: trading record in brief

All filings by Kathryn E. Stein on record concern Macrogenics Inc. In total, 17 filings cover trades dated from 29 May 2014 to 7 January 2016.

Every open-market trade on record is a sale: 6 sales worth €1.5M. Other entries cover 11 option exercises.

The newest entry dates from 11 January 2016: an option exercise, in Macrogenics Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Kathryn E. Stein

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations17 total
  • ◇
    SVP, Product Dev. & RegulatoryExecutivesMacrogenics Inc
    0SEC
    6,658 sharesCommon StockSEC:0001140361-16-047432:0
  • ◇
    SVP, Product Dev. & RegulatoryExecutivesMacrogenics Inc
    0SEC
    8,895 sharesCommon StockSEC:0001140361-16-047432:1
  • ◇
    SVP, Product Dev. & RegulatoryExecutivesMacrogenics Inc
    0SEC
    4,421 sharesCommon StockSEC:0001140361-16-047432:2
  • ◇
    SVP, Product Dev. & RegulatoryExecutivesMacrogenics Inc
    0SEC
    13,316 sharesCommon StockSEC:0001140361-16-047432:3
  • ◇
    SVP, Product Dev. & RegulatoryExecutivesMacrogenics Inc
    0SEC
    19,060 sharesCommon StockSEC:0001140361-16-047432:4
  • ◇
    SVP, Product Dev. & RegulatoryExecutivesMacrogenics Inc
    777 USD0SEC
    10,946 shares@ US$0.071Common StockSEC:0001140361-14-046227:0
  • ▼
    SVP, Product Dev. & RegulatoryExecutivesMacrogenics Inc
    405,002 USD0SEC
    10,946 shares@ US$37.00Common StockSEC:0001140361-14-046227:1
  • ◇
    SVP, Product Dev. & RegulatoryExecutivesMacrogenics Inc
    7,772 USD0SEC
    10,946 shares@ US$0.71Common StockSEC:0001140361-14-046079:0
  • ▼
    SVP, Product Dev. & RegulatoryExecutivesMacrogenics Inc
    361,218 USD0SEC
    10,946 shares@ US$33.00Common StockSEC:0001140361-14-046079:1
  • ◇
    Senior VP, Prd Dev & Reg AffExecutivesMacrogenics Inc
    7,772 USD0SEC
    10,946 shares@ US$0.71Common StockSEC:0001140361-14-043239:0
  • ▼
    Senior VP, Prd Dev & Reg AffExecutivesMacrogenics Inc
    295,542 USD0SEC
    10,946 shares@ US$27.00Common StockSEC:0001140361-14-043239:1
  • ◇
    Senior VP, Prd Dev & Reg AffExecutivesMacrogenics Inc
    21,818 USD0SEC
    23,211 shares@ US$0.94Common StockSEC:0001140361-14-042505:0
  • ▼
    Senior VP, Prd Dev & Reg AffExecutivesMacrogenics Inc
    541,513 USD0SEC
    23,211 shares@ US$23.33Common StockSEC:0001140361-14-042505:1
  • ◇
    Senior VP, Prd Dev & Reg AffExecutivesMacrogenics Inc
    1,965 USD0SEC
    2,090 shares@ US$0.94Common StockSEC:0001140361-14-042505:2
  • ▼
    Senior VP, Prd Dev & Reg AffExecutivesMacrogenics Inc
    47,966 USD0SEC
    2,090 shares@ US$22.95Common StockSEC:0001140361-14-042505:3
  • ◇
    Senior VP, Prd Dev & Reg AffExecutivesMacrogenics Inc
    7,772 USD0SEC
    10,946 shares@ US$0.71Common StockSEC:0001209191-14-037881:0
  • ▼
    Senior VP, Prd Dev & Reg AffExecutivesMacrogenics Inc
    216,184 USD0SEC
    10,946 shares@ US$19.75Common StockSEC:0001209191-14-037881:1

17 of 17 declarations